BRIEF published on 11/25/2025 at 11:48, 9 months 16 days ago Avis de prix final pour l'ISIN XS2999243780 BNP Paribas Prospectus De Base Prix De L'offre Finale ISIN XS2999243780 Montant Nominal Total
BRIEF published on 11/25/2025 at 11:44, 9 months 16 days ago Credit Coopératif Announces Final Offer Prices for Note Issuance AMF Approval Crédit Coopératif Final Offer Prices ISIN XS2999243863 BNP Paribas Issuance
BRIEF published on 11/25/2025 at 11:44, 9 months 16 days ago Credit Coopératif annonce les prix définitifs de son offre d'émission d'obligations Crédit Coopératif Approbation AMF ISIN XS2999243863 Prix De L'offre Finale Émission De BNP Paribas
BRIEF published on 11/25/2025 at 11:35, 9 months 16 days ago Fynd Enters UK Market, Expands Global Presence Strategic Partnerships Global Strategy UK Retail Market AI Commerce Fynd Expansion
BRIEF published on 11/25/2025 at 11:35, 9 months 16 days ago Fynd fait son entrée sur le marché britannique et étend sa présence mondiale. Partenariats Stratégiques Stratégie Globale Extension Find Marché De Détail Britannique Commerce IA
BRIEF published on 11/25/2025 at 11:35, 9 months 16 days ago HRS organise une visioconférence ouverte le 26 novembre 2025 Stratégie Visioconférence Investisseurs Hydrogène HRS
BRIEF published on 11/25/2025 at 11:35, 9 months 16 days ago HRS is organizing an open video conference on November 26, 2025 Investors Strategy Hydrogen HRS Vidéo Conférence
BRIEF published on 11/25/2025 at 11:15, 9 months 16 days ago Chow Tai Fook Jewellery Shows Resilient Growth in 1HFY2026 Revenue Growth Market Expansion Chow Tai Fook Brand Transformation Jewellery Sales
BRIEF published on 11/25/2025 at 11:15, 9 months 16 days ago Le secteur de la joaillerie Chow Tai Fook affiche une croissance résiliente au premier semestre de l'exercice 2026. Croissance Des Revenus Chow Tai Fook Expansion Du Marché Transformation De La Marque Vente De Bijoux
BRIEF published on 11/25/2025 at 11:10, 9 months 16 days ago Exyte Successfully Integrates Pharmaplan to Boost Biopharma Engineering Capabilities Pharmaplan Integration Exyte Expansion Biopharma Engineering EPC/EPCM Delivery Life Sciences Market
Published on 09/12/2026 at 02:35, 58 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 4 hours 33 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 5 hours 28 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 6 hours 8 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 10 hours 33 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 5 hours 18 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 5 hours 23 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 7 hours 48 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 9 hours 18 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 20 hours 33 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 20 hours 33 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 20 hours 33 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 20 hours 33 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 8 hours ago Availability of the 2026 Interim Financial Report
